The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611 · cited 1×
“Hence, it should have an adequate appearance, present a short reconstitution time, as long as being easily resuspended in water, and induce no changes on particle size distribution of nanoparticles, while maintaining the encapsulated drug activity.(15) However, as a general rule, lyophilization of LPs implies aggregat…”
BackgroundLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · cited 1×
“Nanoparticle drug delivery systems have demonstrated to be efficient in overcoming this barrier with several drugs reported to have successfully been transported into the brain using this carrier, including loperamide, dopamine or doxorubicin, among others.(159,160) These drugs could not otherwise indepently permeate…”
BackgroundNanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Epidermal Barrier Dysfunction in Atopic Dermatitis
Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., MacGowan, A. L., Tazi-Ahnini, R., & Ward, S. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.133 · Cited by 765
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Overcoming the Stratum Corneum: The Modulation of Skin Penetration
Trommer, H., & Neubert, R. H. H. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000091978 · Cited by 572
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., & Mäder, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.012 · Cited by 472
Liposomal siRNA nanocarriers for cancer therapy
Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.008 · Cited by 442
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.008 · Cited by 404
Gandhi, N. S., Tekade, R. K., & Chougule, M. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.001 · Cited by 394
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Delivery strategies for sustained drug release in the lungs
Loira-Pastoriza, C., Todoroff, J., & Vanbever, R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 393
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Reis, S., Neves, Lúcio, Martins, & Lima (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37840 · Cited by 368
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Kuntsche, J., Horst, J. C., & Bunjes, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.001 · Cited by 363
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 337
Selective follicular targeting by modification of the particle sizes
Patzelt, A., Richter, H., Knorr, F., Schäfer, U., Lehr, C.-M., Dähne, L., Sterry, W., & Lademann, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.015 · Cited by 330
Taratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Improvement of drug safety by the use of lipid-based nanocarriers
Lim, S. B., Banerjee, A., & Önyüksel, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.002 · Cited by 324
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Mucus as a barrier to lipophilic drugs
Sigurdsson, H. H., Kirch, J., & Lehr, C.-M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.040 · Cited by 280
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00944-9 · Cited by 279
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Tiwari, R., & Pathak, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.044 · Cited by 261
Verhoest, G., Dolley-Hitze, T., Jouan, F., Belaud-Rotureau, M.-A., Oger, E., Lavenu, A., Bensalah, K., Arlot-Bonnemains, Y., Collet, N., Rioux-Leclercq, N., et al. (2014) · BioMed Research International · doi:10.1155/2014/901371 · Cited by 260
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
Gomes-da-Silva, L. C., Fonseca, N. A., Moura, V., Pedroso de Lima, M. C., Simões, S., & Moreira, J. N. (2012) · Accounts of Chemical Research · doi:10.1021/ar300048p · Cited by 254
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery
Chen-yu, G., Chun-fen, Y., Qi-lu, L., Qi, T., Yan-wei, X., Wei-na, L., & Guang-xi, Z. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.042 · Cited by 247
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.020 · Cited by 245
Taratula, O., Garbuzenko, O. B., Chen, A. M., & Minko, T. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.622404 · Cited by 245
Madane, R. G., & Mahajan, H. S. (2016) · Drug Delivery · doi:10.3109/10717544.2014.975382 · Cited by 241
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease
Beloqui, A., Coco, R., Memvanga, P. B., Ucakar, B., des Rieux, A., & Préat, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.009 · Cited by 240
Self-citationLuo, Q., Zhao, J., Zhang, X., & Pan, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.013 · Cited by 234
Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art
Gastaldi, L., Battaglia, L., Peira, E., Chirio, D., Muntoni, E., Solazzi, I., Gallarate, M., & Dosio, F. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.004 · Cited by 222
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC
Teeranachaideekul, V., Boonme, P., Souto, E. B., Müller, R. H., & Junyaprasert, V. B. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.011 · Cited by 215
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Self-citationFormulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib
Joshi, M., & Patravale, V. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600814676 · Cited by 213
Shidhaye, S., Vaidya, R., Sutar, S., Patwardhan, A., & Kadam, V. (2008) · Current Drug Delivery · doi:10.2174/156720108785915087 · Cited by 210
Beloqui, A., Solins, M. N., Gascn, A. R., del Pozo-Rodrguez, A., des Rieux, A., & Prat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.021 · Cited by 208
Self-citationSLN and NLC for topical delivery of ketoconazole
Souto, E. B., & Müller, R. H. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500162436 · Cited by 208
Uprit, S., Kumar Sahu, R., Roy, A., & Pare, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.11.005 · Cited by 201
Saupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 199
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers
Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., & Pan, W.-S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.017 · Cited by 195
Gartziandia, O., Herran, E., Pedraz, J. L., Carro, E., Igartua, M., & Hernandez, R. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.054 · Cited by 194
Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems
Sitterberg, J., Özcetin, A., Ehrhardt, C., & Bakowsky, U. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.005 · Cited by 187
Advances in lipid-based colloid systems as drug carrier for topic delivery
Zhai, Y., & Zhai, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.054 · Cited by 186
Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin Effects
Souto, E. B., Almeida, A. J., & Müller, R. H. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.049 · Cited by 186
Self-citationMendes, A. I., Silva, A. C., Catita, J. A. M., Cerqueira, F., Gabriel, C., & Lopes, C. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.05.041 · Cited by 181
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
Gonzalez-Mira, E., Egea, M. A., Souto, E. B., Calpena, A. C., & García, M. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/4/045101 · Cited by 180
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery
Shen, J., Wang, Y., Ping, Q., Xiao, Y., & Huang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.021 · Cited by 179
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
Nanotherapy for posterior eye diseases
Kaur, I. P., & Kakkar, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.031 · Cited by 175
Gainza, G., Pastor, M., Aguirre, J. J., Villullas, S., Pedraz, J. L., Hernandez, R. M., & Igartua, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.032 · Cited by 172
Araújo, J., Nikolic, S., Egea, M. A., Souto, E. B., & Garcia, M. L. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.06.025 · Cited by 171
Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration
Gaba, B., Fazil, M., Ali, A., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898110 · Cited by 164
Üstündağ-Okur, N., Gökçe, E. H., Bozbıyık, D. İ., Eğrilmez, S., Özer, Ö., & Ertan, G. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.07.013 · Cited by 163
Gupta, M., & Vyas, S. P. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2012.01.006 · Cited by 160
Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis
Beloqui, A., Coco, R., Alhouayek, M., Solinís, M. Á., Rodríguez‐Gascón, A., Muccioli, G. G., & Véronique Préat, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.017 · Cited by 155
Self-citationGabal, Y. M., Kamel, A. O., Sammour, O. A., & Elshafeey, A. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.025 · Cited by 155
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 155
Tran, T. H., Ramasamy, T., Truong, D. H., Choi, H., Yong, C. S., & Kim, J. O. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0175-y · Cited by 153
Zhang, T., Chen, J., Zhang, Y., Shen, Q., & Pan, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.005 · Cited by 152
Formulation of a Novel Oxybenzone-Loaded Nanostructured Lipid Carriers (NLCs)
Sanad, R. A.-B., Abdelmalak, N. S., elBayoomy, T. S., & Badawi, A. A. E.-L. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9553-2 · Cited by 150
Ali, H., Weigmann, B., Neurath, M. F., Collnot, E. M., Windbergs, M., & Lehr, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.039 · Cited by 149
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 148
siRNA Delivery to the lung: What's new?
Merkel, O. M., Rubinstein, I., & Kissel, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.018 · Cited by 147
Vitorino, C., Almeida, J., Gonçalves, L., Almeida, A. J., Sousa, J., & Pais, A. A. C. C. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.011 · Cited by 146
Self-citationFunctions of Lipids for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs
Nanjwade, B. K., Patel, D. J., Udhani, R. A., & Manvi, F. V. (2011) · Scientia Pharmaceutica · doi:10.3797/scipharm.1105-09 · Cited by 146
Ricci, M., Puglia, C., Bonina, F. P., Giovanni, C. D., Giovagnoli, S., & Rossi, C. R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20335 · Cited by 143
Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs
Souto, E. B., Doktorovová, S., González‐Mira, E., Egea, M. A., & García, M. L. (2010) · Current Eye Research · doi:10.3109/02713681003760168 · Cited by 142
Fate of nanomedicines in the lungs
Todoroff, J., & Rita Vanbever, A. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2011.03.001 · Cited by 141
Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.001 · Cited by 141
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Bastiat, G., Pritz, C. O., Roider, C., Fouchet, F., Lignières, E., Jesacher, A., Glueckert, R., Ritsch‐Marte, M., Schrott‐Fischer, A., Saulnier, P., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.014 · Cited by 135
Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans
Cipolla, D. C., Shekunov, B. Y., Blanchard, J., & Hickey, A. J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.001 · Cited by 132
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy
del Pozo‐Rodríguez, A., Solinís, M. Á., Rodríguez‐Gascón, A., & Pedraz, J. L. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.015 · Cited by 129
Self-citationFollicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
Shamma, R. N., & Aburahma, M. H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73010 · Cited by 127
Electron microscopy of pharmaceutical systems
Klang, V., Valenta, C., & Matsko, N. B. (2012) · Micron · doi:10.1016/j.micron.2012.07.008 · Cited by 125
Nanotechnology approaches for ocular drug delivery
Kannan, R. M., Xu, Q., & Kambhampati, S. P. (2013) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.106384 · Cited by 125
Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
Wissing, S. A., & Müller, R. H. (2001) · PubMed · Cited by 124
Structural properties of solid lipid based colloidal drug delivery systems
Bunjes, H. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2011.06.007 · Cited by 124
Varshosaz, J., Eskandari, S., & Tabbakhian, M. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.01.051 · Cited by 123
Vitorino, C., Almeida, A. J., Sousa, J., Lamarche, I., Gobin, P., Marchand, S., Couet, W. R., Olivier, J., & Pais, A. A. C. C. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.004 · Cited by 123
Self-citationNanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Esposito, E., Mariani, P., Ravani, L., Contado, C., Volta, M., Bido, S., Drechsler, M., Mazzoni, S., Menegatti, E., Morari, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.015 · Cited by 121
Devkar, T. B., Tekade, A. R., & Khandelwal, K. R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.06.037 · Cited by 120
Shen, J., Deng, Y., Jin, X., Ping, Q., Su, Z., & Li, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.008 · Cited by 116
Gainza, G., Celdran‐Bonafonte, D., Moreno, B., Aguirre, J. J., Gutiérrez, F. B., Villullas, S., Pedraz, J. L., Igartua, M., & Hernández, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.033 · Cited by 114
Nanostructured lipid carriers as novel carrier for sunscreen formulations
Xia, Q., Saupe, A., Müller, R. H., & Souto, E. B. (2007) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2007.00410.x · Cited by 112
Pardeike, J., Schwabe, K., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.007 · Cited by 111
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23251 · Cited by 111
Liu, Y., Wang, L., Zhao, Y., He, M., Zhang, X., Niu, M., & Feng, N. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.052 · Cited by 108
Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement
Patil-Gadhe, A., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.019 · Cited by 107
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
del Pozo‐Rodríguez, A., Delgado, D., Rodríguez‐Gascón, A., & Solinís, M. Á. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0128 · Cited by 107
Self-citationNanotechnology in ophthalmology
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · Canadian Journal of Ophthalmology · doi:10.3129/i10-090 · Cited by 104
Aljuffali, I. A., Sung, C. T., Shen, F., Huang, C.-T., & Fang, J. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9550-y · Cited by 98
Nnamani, P. O., Hansen, S., Windbergs, M., & Lehr, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.004 · Cited by 97
Gönüllü, Ü., Üner, M., Yener, G., Karaman, E. F., & Aydoğmuş, Z. (2015) · Acta Pharmaceutica · doi:10.1515/acph-2015-0009 · Cited by 96
Lipid nanoparticles: perspectives and challenges☆
Gasco, M. R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.004 · Cited by 96
Beloqui, A., Solinís, M. Á., Rieux, A. D., Véronique Préat, A., & Rodríguez‐Gascón, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.027 · Cited by 93
Self-citationUltra-small NLC for improved dermal delivery of coenyzme Q10
Schwarz, J. C., Baisaeng, N., Hoppel, M., Löw, M., Keck, C. M., & Valenta, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.037 · Cited by 91
Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin
Shangguan, M., Lü, Y., Qi, J., Han, J., Tian, Z., Xie, Y., Hu, F., Yuan, H., & Wu, W. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213485141 · Cited by 89
Chen, S., Liu, W., Wan, J., Cheng, X., Gu, C., Zhou, H., Chen, S., Zhao, X., Tang, Y., & Yang, X. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.650648 · Cited by 88
Nanomedicine in Ophthalmology: The New Frontier
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.03.019 · Cited by 88
Evaluation of alternative strategies to optimize ketorolac transdermal delivery
Puglia, C., Filosa, R., Peduto, A., Caprariis, P. D., Rizza, L., Bonina, F. P., & Blasi, P. (2006) · AAPS PharmSciTech · doi:10.1208/pt070364 · Cited by 83
Shete, H. K., Chatterjee, S., De, A., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.036 · Cited by 82
Schneider, H., Braun, A., Füllekrug, J., Stremmel, W., & Ehehalt, R. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11104149 · Cited by 81
Pharmaceutical and Biomedical Applications of lipid-based Nanocarriers
Carbone, C., Leonardi, A., Cupri, S., Puglisi, G., & Pignatello, R. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.13.79 · Cited by 79
Puglia, C., Frasca, G., Musumeci, T., Rizza, L., Puglisi, G., Bonina, F. P., & Chiechio, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.03.015 · Cited by 77
Kong, F., Han, Y., Zhang, Y., Li, D., Chen, Y., & Sun, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67770 · Cited by 77
Improved and Safe Transcorneal Delivery of Flurbiprofen by NLC and NLC-Based Hydrogels
González‐Mira, E., Nikolić, S., Calpena, A. C., Egea, M. A., Souto, E. B., & García, M. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22784 · Cited by 76
Schwarz, J. C., Weixelbaum, A., Pagitsch, E., Löw, M., Resch, G. P., & Valenta, C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.003 · Cited by 71
Pastor, M., Moreno-Sastre, M., Esquisabel, A., Sans, E., Viñas, M., Bachiller, D., Asensio, V. J., del Pozo, Á., Gaínza, E., & Pedraz, J. L. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.048 · Cited by 71
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells
Landesman‐Milo, D., Goldsmith, M., Ben‐Arye, S. L., Witenberg, B., Brown, E., Leibovitch, S., Azriel, S., Tabak, S., Morad, V., & Peer, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.024 · Cited by 68
Formulation of anastrozole microparticles as biodegradable anticancer drug carriers
Zidan, A. S., Sammour, O. A., Hammad, M. A., et al. (2006) · AAPS PharmSciTech · doi:10.1208/pt070361 · Cited by 65
Mandpe, L., & Pokharkar, V. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.867445 · Cited by 63
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., del Pozo‐Rodríguez, A., & Rodríguez‐Gascón, A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.029 · Cited by 63
Self-citationYuan, L., Zhang, Z., Wei, C., Zhou, L., Wu, Q., & Chen (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34991 · Cited by 62
Therapeutic Use of MicroRNAs in Lung Cancer
Fortunato, O., Boeri, M., Verri, C., Moro, M., & Sozzi, G. (2014) · BioMed Research International · doi:10.1155/2014/756975 · Cited by 61
Kawadkar, J., Pathak, A., Kishore, R., & Chauhan, M. K. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.686509 · Cited by 61
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., Isla, A., & Rodríguez‐Gascón, A. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2013.788090 · Cited by 60
Self-citationHsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 59
Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity
Blasi, P., Schoubben, A., Traina, G., Manfroni, G., Barberini, L., Alberti, P. F., Cirotto, C., & Ricci, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.037 · Cited by 59
Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying
Dulieu, C., & Bazile, D. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1196-0 · Cited by 55
Tian, B., Luo, Q., Song, S., Liu, D., Pan, H., Zhang, W., He, L., Shi-lin, M., Yang, X., & Pan, W. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22813 · Cited by 55
Desai, P. R., Shah, P. P., Patlolla, R. R., & Singh, M. S. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0789-2 · Cited by 51
Silva, A. C., Santos, D. F. G., Ferreira, D., & Souto, E. B. (2009) · Die Pharmazie · doi:10.31083/ph.2009.8232 · Cited by 50
Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide
Saliou, B., Thomas, O., Lautram, N., Clavreul, A., Hureaux, J., Urban, T., Benoît, J., & Lagarce, F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.06.013 · Cited by 50
Lymphatic uptake of lipid nanoparticles following endotracheal administration
Videira, M., Gano, L., dos Santos, C. P., Neves, M., & Almeida, A. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788221 · Cited by 49
Self-citationAdvanced systems for glucocorticoids' dermal delivery
Raposo, S., Simões, S., Almeida, A. J., & Ribeiro, H. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.778824 · Cited by 43
Self-citationLipid nanoparticles for brain targeting II. Technological characterization
Blasi, P., Schoubben, A., Romano, G. V., Giovagnoli, S., Michele, A. D., & Ricci, M. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.04.021 · Cited by 41
Shete, H. K., Selkar, N., Vanage, G. R., & Patravale, V. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.056 · Cited by 36
Vitorino, C., Alves, L., Antunes, F. E., Sousa, J., & Pais, A. A. C. C. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1993-7 · Cited by 34
Zhao, C., Fan, T., Yang, Y., Wu, M., Li, L., Zhou, Z., Jian, Y., Zhang, Q., & Huang, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.030 · Cited by 29
Nano-vectors for the ocular delivery of nucleic acid-based therapeutics
Khar, R. K., Warsi, M. H., Akhter, S., Ahmad, F., Jain, G. K., Mallick, N., & Pathan, S. (2010) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.84575 · Cited by 26
Cited by
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Metadata
- Authors
- Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 12
- Issue
- 1
- Pages
- 143-161
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W1734250133
- Cited by
- 769
- References
- 152
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.